
Lupin Limited has informed the Exchange about press release dated 25-Aug-2022 titled Lupin and I���rom Enter into an Exclusive Licensing Agreement for Denosumab biosimilar for Japan.
Filed with NSE ·

Lupin Limited has informed the Exchange about press release dated 25-Aug-2022 titled Lupin and I���rom Enter into an Exclusive Licensing Agreement for Denosumab biosimilar for Japan.
6ix hasn’t read this filing yet.
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin